Application of CRISPR-Cas System to Mitigate Superbug Infections

Area of Science:

• Microbiology
• Genetics
• Biotechnology

Background:

• Multidrug-resistant bacteria (superbugs) cause fatal global infections, exacerbated by urbanization and poor sanitation.
• The CRISPR-Cas system presents a promising tool for precise genomic editing of antibiotic-resistant bacteria.

Purpose of the Study:

• To review limitations of the CRISPR-Cas system for combating superbugs.
• To explore base-editing techniques as advanced strategies to overcome CRISPR-Cas limitations.
• To highlight research on base editors' efficacy in eliminating drug-resistant microbes.

Main Methods:

• Review of CRISPR-Cas system limitations.
• Exploration of base-editing techniques, including adenine base editors (ABE) and cytidine base editors (CBE).
• Analysis of methods for precise single base pair editing without double-strand breaks (DSBs).

Main Results:

• Base editors (ABE and CBE) enable precise point mutations (e.g., G-C to A-T) without DSBs.
• These engineered Cas9 variations offer enhanced precision and reduced toxicity compared to standard CRISPR-Cas.
• Recent studies demonstrate the potential of base editors to effectively eliminate drug-resistant bacterial strains.

Conclusions:

• Advanced base-editing techniques are crucial for maximizing the potential of CRISPR-Cas in fighting antibiotic resistance.
• Base editors provide a viable strategy to precisely target and neutralize superbug genomes.
• Further development in base editing promises more effective treatments against drug-resistant infections.